CareDx (NASDAQ:CDNA – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Wednesday, July 31st. Analysts expect CareDx to post earnings of ($0.13) per share for the quarter. CareDx has set its FY 2024 guidance at EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.
CareDx (NASDAQ:CDNA – Get Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.46) by $0.18. CareDx had a negative return on equity of 55.08% and a negative net margin of 66.59%. The company had revenue of $72.05 million during the quarter, compared to the consensus estimate of $63.63 million. On average, analysts expect CareDx to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
CareDx Stock Down 1.5 %
Shares of CDNA stock opened at $18.72 on Tuesday. The company has a 50 day moving average price of $15.55 and a 200-day moving average price of $11.92. CareDx has a 52 week low of $4.80 and a 52 week high of $19.58. The firm has a market capitalization of $974.94 million, a PE ratio of -5.47 and a beta of 1.78.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on CDNA
CareDx Company Profile
CareDx, Inc engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.
Further Reading
- Five stocks we like better than CareDx
- The How And Why of Investing in Oil Stocks
- Why This Manufacturer is Committing to a Massive Buyback Program
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
- Insider Trading – What You Need to Know
- Healthcare Stock Rides the Acute Services Phenomenon to New Highs
Receive News & Ratings for CareDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx and related companies with MarketBeat.com's FREE daily email newsletter.